We categorized the patients based on their infection status, albumin levels, prothrombin activity, and outcomes, and found that ACLF patients with infections, low albumin levels, low prothrombin activity, and poor prognosis had significantly decreased surface marker expression on monocyte-derived dendritic cells. This evidence concerns the gene F2 and infection.